01 26Belmore Neidrauer LLP
02 18Blake Cassels & Graydon LLP
01 122534024
02 122671357
03 22712614
04 122767811
05 62799204
01 10CANAGLIFLOZIN
02 22CANAGLIFLOZIN | METFORMIN HYDROCHLORIDE
03 12METFORMIN HYDROCHLORIDE | CANAGLIFLOZIN
01 22TABLET
02 16TABLET (EXTENDED-RELEASE)
03 6TABLET (IMMEDIATE RELEASE)
01 122024-07-30
02 122027-12-03
03 22029-01-16
04 122030-07-07
05 62031-05-11
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Brand Name : INVOKANA
Patent Number : 2534024
Filing Date : 2004-07-30
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
Brand Name : INVOKANA
Patent Number : 2671357
Filing Date : 2007-12-03
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Brand Name : INVOKANA
Patent Number : 2534024
Filing Date : 2004-07-30
Strength per Unit : 300 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
Brand Name : INVOKANA
Patent Number : 2671357
Filing Date : 2007-12-03
Strength per Unit : 300 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE
Brand Name : INVOKAMET
Patent Number : 2534024
Filing Date : 2004-07-30
Strength per Unit : 50 mg / 850 mg
Dosage Form : TABLET (IMMEDIATE RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
METFORMIN HYDROCHLORIDE, CANAGLIFLOZIN
Brand Name : INVOKAMET
Patent Number : 2671357
Filing Date : 2007-12-03
Strength per Unit : 50 mg / 1000 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
METFORMIN HYDROCHLORIDE, CANAGLIFLOZIN
Brand Name : INVOKAMET
Patent Number : 2534024
Filing Date : 2004-07-30
Strength per Unit : 50 mg / 1000 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
METFORMIN HYDROCHLORIDE, CANAGLIFLOZIN
Brand Name : INVOKAMET
Patent Number : 2671357
Filing Date : 2007-12-03
Strength per Unit : 150 mg / 500 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
METFORMIN HYDROCHLORIDE, CANAGLIFLOZIN
Brand Name : INVOKAMET
Patent Number : 2534024
Filing Date : 2004-07-30
Strength per Unit : 150 mg / 500 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-07-30
Date Granted : 2009-06-02
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE
Brand Name : INVOKAMET
Patent Number : 2671357
Filing Date : 2007-12-03
Strength per Unit : 150 mg / 850 mg
Dosage Form : TABLET (IMMEDIATE RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-12-03
Date Granted : 2011-11-01
